Pharmacokinetics of meropenem in animals, healthy volunteers, and patients

Clinical Infectious Diseases

Volumn 24, Issue SUPPL. 2, 1997, Pages

  Moon, Yong S K ^b   Chung, Karen C ^b   Gill, Mark A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; MEROPENEM;

AGE; AREA UNDER THE CURVE; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG PROTEIN BINDING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; NONHUMAN; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; VOLUNTEER;

EID: 0030977235     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_2.s249     Document Type: Review

References (9)

1. Moellering RC Jr, Eliopoulos GM, Sentochnik DE. The carbapenems: new broad spectrum β-lactam antibiotics. J Antimicrob Chemother 1989; 24(suppl A):1-7.
2. Pryka RD, Haig GM. Meropenem: a new carbapenem antimicrobial. Ann Pharmacother 1994;28:1045-53.
3. Nord CE, Lindmark A, Persson I. Susceptibility of anaerobic bacteria to meropenem. J Antimicrob Chemother 1989;24(suppl A): 113-7.
4. Nichols RL, Smith JW, Geckler RW, Wilson SE. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. South Med J 1995; 88:397-404.
5. Lami JL, Wilson SE, Hopkins JA. Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems. Am Surg 1991;57:769-74.
6. Smith I, Muzik A, Nichols RL, et al. Randomized comparative study of meropenem vs imipenem-cilastatin in the treatment of skin and skin structure infections [abstract no 612]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991.
7. Cox CE, Holloway WJ, Geckler RW. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clin Infect Dis 1995; 21:86-92.
8. Naber KG. Efficacy of meropenem in both complicated and uncomplicated urinary tract infections: comparison with ceftazidime. In: Proceedings of the Meropenem Workshop. (Athens, Greece). 1992.
9. Condon RE, Walker AP, Hanna CB, Greenberg RN, Broom A, Pitkin D. Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery. Clin Infect Dis 1997;24(suppl 2):S181-3.